These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 16403053
1. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H, MADIT II Investigators. J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1265-70. PubMed ID: 16403053 [Abstract] [Full Text] [Related]
2. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ, Multicenter Automatic Defibrillator Implantation Trial II investigators. J Am Coll Cardiol; 2004 Oct 06; 44(7):1481-7. PubMed ID: 15464332 [Abstract] [Full Text] [Related]
3. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ, MADIT-II Investigators. J Am Coll Cardiol; 2005 Nov 01; 46(9):1712-20. PubMed ID: 16256874 [Abstract] [Full Text] [Related]
10. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU, MADIT-II Investigators. J Am Coll Cardiol; 2006 May 02; 47(9):1811-7. PubMed ID: 16682305 [Abstract] [Full Text] [Related]
11. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction. Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I, Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Am J Cardiol; 2010 Mar 01; 105(5):581-6. PubMed ID: 20185000 [Abstract] [Full Text] [Related]
13. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML, MADIT-II Investigators. J Am Coll Cardiol; 2008 Jan 22; 51(3):288-96. PubMed ID: 18206738 [Abstract] [Full Text] [Related]
18. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S. J Am Coll Cardiol; 2006 Jul 04; 48(1):112-21. PubMed ID: 16814657 [Abstract] [Full Text] [Related]
19. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, Cygankiewicz I, Zareba W, Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation; 2010 Sep 28; 122(13):1265-71. PubMed ID: 20837894 [Abstract] [Full Text] [Related]
20. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators. Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W. J Cardiovasc Electrophysiol; 2009 Apr 28; 20(4):395-400. PubMed ID: 19017351 [Abstract] [Full Text] [Related] Page: [Next] [New Search]